$12.91
-0.04-0.30%
At close: Sep 20, 7:57 PM EDT
$12.87
-0.04-0.30%
After Hours: Sep 20, 7:57 PM EDT
15 minutes delayed
Novavax reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Novavax using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $0.99 | $1.36 | -27.2 % |
Mar 2024 | 2024-05-10 | $-1.05 | $-1.06 | 0.94 % |
Dec 2023 | 2024-02-28 | $-1.47 | $-0.45 | -226.7 % |
Sep 2023 | 2023-11-09 | $-1.26 | $-1.83 | 31.1 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $415.48M | $414.82M | 0.16 % |
Mar 2024 | 2024-05-10 | $93.86M | $101.16M | -7.22 % |
Dec 2023 | 2024-02-28 | $291.34M | $321.65M | -9.42 % |
Sep 2023 | 2023-11-09 | $186.99M | $158.54M | 17.9 % |
Novavax (NVAX) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $0.99, which missed the estimate of $1.36.
The Actual Revenue was $415.5M, which beat the estimate of $414.8M.
Browse earnings estimates, EPS, and revenue on all stocks.